Health
AstraZeneca Could Price Poor Out Of COVID Vaccine After Pandemic, Warns Trial Volunteer – HuffPost
The pharma giant said it was “too early to comment on pricing post-pandemic” for the coronavirus drug it is trialing at Oxford University.
AstraZeneca could price poorer countries out of a British coronavirus vaccine in the future due to a loophole in the nonprofit agreement it signed with Oxford University, campaigners have warned – among them one of the first participants in the trial itself.
Volunteer Luigi Ceccaroni has demanded the details of a distribution deal between Oxford University and the pharma giant be made public, saying he fears the firm could still profiteer from the drug once the first global peak dies down. Astr…
-
Noosa News16 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General17 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News19 hours agoMirvac to sell site to Irvine Group
-
General16 hours agoWoolworths executive was hospitalised by 100-hour-a-week workload, lawsuit claims